BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results

  July 29, 2025

   · 

  38 min read
• Press Releases

  Delay in CE Approval for XVIVO’s Perfusion Solution for Heart Preservation

  July 29, 2025

   · 

  3 min read
• Press Releases

  Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer

  July 29, 2025

   · 

  3 min read
• Press Releases

  FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

  July 29, 2025

   · 

  14 min read
• Press Releases

  Pahr Therapeutics Raises $14 Million Seed Financing to Pursue Innovative Treatments for Pulmonary Arterial Hypertension

  July 29, 2025

   · 

  1 min read
• Press Releases

  Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025

  July 29, 2025

   · 

  2 min read
• Press Releases

  Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces

  July 29, 2025

   · 

  4 min read
• Press Releases

  Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

  July 29, 2025

   · 

  7 min read
• Press Releases

  Philips builds strong order intake momentum and drives margin expansion in Q2

  July 29, 2025

   · 

  10 min read
• Press Releases

  Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze

  July 29, 2025

   · 

  7 min read